• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Another quarterly update?


<











Similar threads

Replies
103
Views
44K
Allergan
anonymous
Replies
18
Views
2K
Replies
19
Views
5K
Replies
5
Views
907